Valuation IOL Chemicals and Pharmaceuticals Limited NSE India S.E.
Stocks
IOLCP
INE485C01029
Pharmaceuticals
|
Market Closed -
NSE India S.E.
07:05:08 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 205.71 INR | -1.76% |
|
+0.74% | +150.07% |
| 09-11 | IOL Chemicals and Pharmaceuticals Limited - Special Call | |
| 08-13 | IOL Chemicals and Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 13, 2026 |
Company Valuation: IOL Chemicals and Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 16,608 | 21,222 | 17,964 | 21,354 | 60,349 | - |
| Change | - | 27.78% | -15.35% | 18.87% | 182.61% | - |
| Enterprise Value (EV) | 16,608 | 21,222 | 17,964 | 21,354 | 60,349 | 60,349 |
| Change | - | 27.78% | -15.35% | 18.87% | 182.61% | 0% |
| P/E | 11.9x | 15.8x | 17.8x | 15.5x | 27.9x | 20.1x |
| PBR | 1.1x | 1.32x | 1.06x | 1.19x | 3.14x | 2.82x |
| PEG | - | -4.68x | -0.7x | 0.4x | 0.5x | 0.5x |
| Capitalization / Revenue | 0.75x | 1x | 0.86x | 0.92x | 2.2x | 1.91x |
| EV / Revenue | 0x | 0x | 0x | 0x | 2.2x | 1.91x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 16.5x | 12.4x |
| EV / EBIT | 0x | 0x | 0x | 0x | 19.3x | 14.1x |
| EV / FCF | -0x | 0x | -0x | 0x | 21.8x | 33.3x |
| FCF Yield | -5.39% | 0.78% | -1.94% | 1.94% | 4.6% | 3.01% |
| Dividend per Share 2 | 0.8 | 1 | 4 | - | - | - |
| Rate of return | 1.41% | 1.38% | 6.54% | - | - | - |
| EPS 2 | 4.74 | 4.58 | 3.44 | 4.69 | 7.5 | 10.4 |
| Distribution rate | 16.9% | 21.8% | 116% | - | - | - |
| Net sales 1 | 22,171 | 21,328 | 20,792 | 23,191 | 27,424 | 31,525 |
| EBITDA 1 | 2,257 | 2,306 | 2,023 | 2,690 | 3,647 | 4,860 |
| EBIT 1 | 2,051 | 1,677 | 1,303 | 1,887 | 3,123 | 4,295 |
| Net income 1 | 1,391 | 1,344 | 1,011 | 1,376 | 2,198 | 3,060 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 56.58 | 72.30 | 61.20 | 72.75 | 209.45 | 209.45 |
| Nbr of stocks (in thousands) | 293,528 | 293,528 | 293,528 | 293,528 | 293,528 | - |
| Announcement Date | 4/28/23 | 5/14/24 | 5/16/25 | 5/20/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 32.45x | 11.78x | 23.93x | 0.61% | 1,019B | ||
| 28.48x | 6.32x | 17.74x | 2.09% | 617B | ||
| 33.26x | 7.78x | 16.08x | 2.64% | 464B | ||
| 104.98x | 5.87x | 24.89x | 2.36% | 356B | ||
| 18.81x | 4.58x | 11.36x | 2.9% | 333B | ||
| 19.83x | 5.17x | 12.78x | 3.09% | 267B | ||
| 20.02x | 4.17x | 11.86x | 2.13% | 244B | ||
| 25.46x | 6.66x | 11.86x | 2.5% | 218B | ||
| -43.78x | 6.39x | 24.97x | 2.27% | 179B | ||
| Average | 26.61x | 6.52x | 17.28x | 2.29% | 410.8B | |
| Weighted average by Cap. | 31.80x | 7.61x | 18.61x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IOLCP Stock
- IOLCP Stock
- Valuation IOL Chemicals and Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















